Section 503A Sample Clauses
Section 503A establishes the regulatory framework for pharmacy compounding of human drug products by licensed pharmacists or physicians. It sets out specific requirements that must be met for compounded drugs to be exempt from certain federal standards, such as those related to new drug approval, labeling, and manufacturing practices. For example, it applies to drugs compounded based on a valid prescription for an individual patient and restricts the use of certain bulk drug substances. The core function of Section 503A is to ensure that compounded medications are prepared safely for individual patients while providing regulatory flexibility for pharmacies and physicians, thereby balancing patient access to customized medications with public health protections.
Section 503A. Global Preferred Securities.......................................................25 Section 504. Registration of Transfer and Exchange of Preferred Securities Certificates.........................................................27 Section 505. Mutilated, Destroyed, Lost or Stolen Trust Securities Certificates................28
Section 503A. Global Preferred Securities................................................................. 28
Section 503A. Global Preferred Security....
Section 503A. Global Trust Preferred Security.......................................................22
Section 503A. Global Preferred Security. . . . . . . . . . .
Section 503A. Global Preferred Securities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 21 Section 504. Registration of Transfer and Exchange of Preferred Securities Certificates . . . . . . . . 23 Section 505. Mutilated, Destroyed, Lost or Stolen Trust Securities Certificates. . . . . . . . . . . . . 24